IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway; however, knockdown of IFITM3-induced apoptosis and inhibited their migration (Liu et al, 2019). Here, IFITM3 is linked to prostate carcinoma.